Temozolomide as adjuvant treatment for people with newly diagnosed anaplastic astrocytoma without 1p/19q codeletion following surgery and radiotherapy (Adults)

Document first published:
Page updated:
Topic:
Publication type:
,

NHS England will commission temozolomide as adjuvant treatment for people with newly diagnosed anaplastic astrocytoma without 1p/19q codeletion following surgery and radiotherapy (Adults) in accordance with the criteria outlined in this document.

Document

Temozolomide as adjuvant treatment for people with newly diagnosed anaplastic astrocytoma without 1p/19q codeletion following surgery and radiotherapy (adults)

Temozolomide as adjuvant treatment for people with newly diagnosed anaplastic astrocytoma without 1p/19q codeletion following surgery and radiotherapy (adults)

  • PDF
  • 96 KB
  • 16 pages

Document

Clinical Panel Report

Clinical Panel Report

  • PDF
  • 22 KB
  • 2 pages

Document

Consultation Report

Consultation Report

  • PDF
  • 90 KB
  • 3 pages

Document

CPAG Summary Report

CPAG Summary Report

  • PDF
  • 129 KB
  • 6 pages

Document

Stakeholder Engagement Report

Stakeholder Engagement Report

  • PDF
  • 35 KB
  • 3 pages

Document

Evidence Review

Evidence Review

  • PDF
  • 784 KB
  • 32 pages